Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Size: px
Start display at page:

Download "Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved"

Transcription

1 UNAIDS DATA TABLES 2011

2 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved UNAIDS / JC2225E The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. UNAIDS does not warrant that the information published in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

3 UNAIDS DATA TABLES 2011

4 Overview Gains continue to be made in the response to the global HIV epidemic. New HIV infections are falling, fewer people are dying of AIDS-related causes and more people with HIV are living longer. There were 2.7 million [2.4 million 2.9 million] new HIV infections in 2010, down 21% from the peak of the global epidemic in HIV incidence has fallen in 33 countries, 22 of them in sub-saharan Africa, the region most affected by the AIDS epidemic. Declines in new HIV infections across the world have been spurred in particular by changes in behaviour among young people, sex workers and their clients, people who inject drugs, men who have sex with men and transgender people, as well as by greatly increased access to HIV prevention services. Increased access to services for eliminating new HIV infections among children and keeping mothers alive has led to a 30% drop in the annual number of new infections among children since 2002 and An estimated [ ] children were newly infected with HIV in 2010, 30% fewer than the peak of [ ] new infections annually in 2002 and At the end of 2010, an estimated 34 million [31.6 million 35.2 million] people were living with HIV worldwide, up 17% from This reflects both new HIV infections and the significant expansion of antiretroviral therapy, which is helping to reduce AIDS-related deaths. HIV prevalence declined among young people (aged years) in at least 21 of 24 countries with national HIV prevalence of 1% or higher. An estimated 6.6 million people in low- and middle-income countries were receiving HIV treatment at the end of 2010 an increase of more than 1.35 million over 2009 and nearly half of those eligible. As a consequence of expanded treatment, AIDS-related deaths are decreasing, and growing numbers of people with HIV are living longer and productive lives. The number of people dying from AIDS-related causes fell to 1.8 million [1.6 million 1.9 million] in 2010, down from a peak of 2.2 million [2.1 million 2.5 million] ion the mid 2000s. A total of 2.5 million AIDS-related deaths have been averted since 1995 due to antiretroviral therapy being introduced, according to new calculations by UNAIDS. These global trends, however, obscure important regional variations, some positive, some not. Impressive as the overall gains are, only a handful of countries have achieved the levels of HIV service coverage needed to eventually halt the epidemic. The accompanying data tables describe in greater detail the progress being made against the HIV epidemic and the main challenges to achieving zero HIV infections and zero AIDS deaths. These tables are a new complement to the AIDSinfo database and have been designed to provide a dynamic interface for research. Readers can sort the data by country and by year in order to explore the detail and evolution of the AIDS epidemic. The data are drawn from country progress reports and will be updated regularly. This document reflects information found in the publication Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011, by UNAIDS, UNICEF and WHO. 2 UNAIDS DATA TABLES 2011

5 Provision of antiretroviral therapy Access to antiretroviral treatment, by region, MILLIONS Middle East and North Africa Europe and Central Asia East, South and South East Asia Latin America and the Caribbean Sub-Saharan Africa End 2002 End 2003 End 2004 End 2005 End 2006 End 2007 End 2008 End 2009 End 2010 The number of people accessing antiretroviral therapy in low- and middle-income countries continues to rise, and reached an estimated 6.6 million at the end of This represented an increase of more than 1.4 million people, or 27%, from a year earlier, and a 16-fold increase from about patients recorded at the end of In addition, at least people were receiving antiretroviral therapy in high-income countries at the end of 2010, including about in Europe, in North America and the Caribbean, and in Asia, Oceania and the Middle East. This means that almost 7.4 million people worldwide, including in high-income countries, were accessing antiretroviral therapy at the end of In total, 1.7 million people initiated treatment in 2010; of these, 1.4 million were alive and on treatment at the end of Ten low- and middle-income countries (Botswana, Cambodia, Chile, Croatia, Cuba, Guyana, Namibia, Nicaragua, Rwanda and Slovakia) had achieved universal access to antiretroviral therapy (defined as providing antiretroviral therapy to at least 80% of patients in need) by the end of Seven other countries (Argentina, Brazil, Dominican Republic, Mexico, Swaziland, Uruguay and Zambia) had coverage levels between 70% and 79% countries provided data on eligible adults and children who newly initiated antiretroviral therapy during 2010, representing 95% of all people on antiretroviral therapy in UNAIDS DATA TABLES

6 Sub-Saharan Africa accounted for 73% of the estimated treatment need in low- and middle-income countries, and 76% of the total number of people receiving treatment at the end of Importantly, it also recorded the biggest increase in the number of people receiving treatment, from 3.9 million in December 2009 to about 5.1 million a year later, a 30% rise. The rates of increase were less than 20% in all the other regions. Coverage of antiretroviral therapy in low- and middle-income countries reached 47% [44% 50%] in 2010 (up from 39% [37% 42%] a year earlier), which meant that 6.6 million people of the 14.2 million [13.4 million 15 million] eligible for treatment were receiving it. Coverage in sub-saharan Africa was 49% [46% 52%] in 2010, but varied considerably among subregions. Whereas 56% [53% 59%] of people eligible for antiretroviral therapy in East and Southern Africa were receiving it, coverage in West and Central Africa stood at 30% [28% 33%]. Antiretroviral treatment coverage improved across all other regions as well, but was lowest in the Middle East and North Africa where 10% [8% 13%]) of people eligible for antiretroviral therapy were receiving it in 2010, while coverage was only 23% [20% 26%] in Eastern Europe and Central Asia and 39% [36% 44%] in East, South and South-East Asia. In those regions, a number of countries are experiencing HIV epidemics that are concentrated among key affected populations for whom treatment and care services are often difficult to access. Access to antiretroviral therapy among women and children Antiretroviral therapy coverage generally appears to be higher among women than men. Across all lowand middle-income countries, an estimated 53% of women eligible for treatment were receiving it at the end of 2010, compared with 40% of men. 2 Coverage was notably higher for women than men in East, South and South-East Asia, and in sub-saharan Africa. But in the Caribbean, coverage was higher among men than women. The number of children younger than 15 years who were receiving antiretroviral therapy increased by 28% between 2009 and 2010, from an estimated to However, coverage of antiretroviral therapy among children and adolescents continues to be considerably lower than among adults, and stood at about 23% [20% 25%] at the end of Coverage was especially low in sub-saharan Africa: 21% [19% 24%], in a region that accounts for about 91% of global paediatric treatment need. An estimated of the 1.8 million children needing antiretroviral therapy in that region were receiving it at the end of Elsewhere, coverage was highest in Eastern Europe and Central Asia (65% [55% 71%]) and Latin America (44% [36% 55%]), and lowest in the Middle East and North Africa (5% [3% 7%]). 2 Data disaggregated by sex on the number of people receiving and needing antiretroviral therapy are available from 110 low- and middleincome countries, representing 95% of the 6.6 million people receiving treatment in A total of 142 countries reported data disaggregated for adults and children. 4 UNAIDS DATA TABLES 2011

7 Number of adults and children receiving and eligible for antiretroviral therapy, and estimated coverage in low- and middle-income countries by region, December 2009 to December 2010 a-c December 2010 December 2009 Geographical region Number of people receiving antiretroviral therapy Estimated number of people needing antiretroviral therapy [range] a Number Antiretroviral of people therapy receiving coverage antiretroviral [range] d therapy Estimated number of people needing antiretroviral therapy [range] a Antiretroviral therapy coverage [range] d Sub-Saharan Africa Eastern and southern Africa Western and central Africa Latin America & the Caribbean Latin America Caribbean East, South & South-East Asia Europe and Central Asia North Africa & the Middle East Total % % [ ] [46% 52%] [ ] [38% 43%] % % [ ] [53% 59%] [ ] [43% 48%] % % [ ] [28% 33%] [ ] [25% 30%] % % [ ] [57% 73%] [ ] [54% 70%] % % [ ] [57% 74%] [ ] [53% 70%] % % [ ] [53% 67%] [ ] [50% 63%] % % [ ] [36% 44%] [ ] [31% 37%] % % [ ] [20% 26%] [ ] [19% 25%] % % [ ] [8% 13%] [ ] [7% 12%] % % [ ] [44% 50%] [ ] [37% 42%] Note: some numbers do not add up because of rounding. a See Box 5.9 for further information on the methods for estimating the need for and coverage of antiretroviral therapy in b The 2009 figures may differ from those previously published because countries have submitted newly available data. c All estimated needs have been developed according to 2010 WHO guidelines and criteria for initiating treatment. d The coverage estimate is based on the unrounded estimated numbers of people receiving and needing antiretroviral therapy. UNAIDS DATA TABLES

8 Preventing and treating HIV infections in women and children New HIV infections among children globally are decreasing steadily, from [ ] in 2000, to [ ] in 2009 and [ ] in The rate of mother-to-child transmission of HIV is estimated to have declined from 35% in 2001, to 29% in 2009, and 26% in It is estimated that more than new infections among children have been averted since 1995 due to the provision of antiretroviral prophylaxis to HIV-positive pregnant women. The Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 4 aims, among other goals, to cut the number of new HIV infections among children by 90% by 2015 (from in 2009 to ) and reduce the rate of mother-to-child transmission to less than 5%. Despite the recent progress, however, those targets are unlikely to be met on current trends. In order to hasten progress, 22 countries (21 from sub-saharan Africa, plus India), which together account for nearly 90% of all pregnant women living with HIV, have been identified as priority countries in the Global Plan. 5 Preventing new HIV infections among women of reproductive age is a vital step toward reaching the Global Plan targets, which call for a 50% reduction in HIV incidence in women aged between 2009 and Since 2001, HIV incidence among adult women in sub-saharan Africa has declined from 0.72 [ ] to 0.49 [ ], while adult HIV incidence rates declined considerably between 2001 and 2010 in several of the priority countries (including in Botswana, Côte d Ivoire, Namibia and Zimbabwe, where they fell by at least 50% or more). Eliminating mother-to-child transmission of HIV requires identifying nearly all pregnant women living with HIV. In 2010, an estimated 35% of pregnant women (43.2 million of the estimated 123 million) in low- and middle-income countries received an HIV test, more than the 26% who did so in 2009, and considerably more than the 8% in The increases occurred in almost all regions, including in East and Southern Africa (where HIV testing coverage expanded from 52% 61% in ), and East, South and South-East Asia (18% 30%). Among the 22 priority countries, coverage of HIV testing and couselling exceeded 90% in Botswana, South Africa, Zambia and Zimbabwe in An additional five countries have reached more than 80% coverage: Kenya, Mozambique, Namibia, Swaziland, and the United Republic of Tanzania. Elsewhere, however, large numbers of pregnant women with HIV still do not know they have been infected and 4 The Global Plan requires progress in four key areas: primary prevention of HIV infection among women of childbearing age; preventing unintended pregnancies among women living with HIV; preventing HIV transmission from women living with HIV to their infants; and providing appropriate treatment, care and support to mothers living with HIV, and their children and families. 5 Angola, Botswana, Burundi, Cameroon, Chad, Côte d Ivoire, Democratic Republic of the Congo, Ethiopia, Ghana, India, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia and Zimbabwe. ô 6 UNAIDS DATA TABLES 2011

9 need to access services that can protect their health and that of their unborn infants. Fewer than 20% of pregnant women living with HIV were identified in Chad, Democratic Republic of the Congo and Nigeria (also priority countries). In low- and middle-income countries overall in 2010, about one third of the estimated 1.5 million women needing antiretroviral drugs to prevent mother-to-child transmission of HIV were still unaware of their HIV status. Providing treatment, care and support to those women and to their children and families constitutes a further, vital step towards eliminating mother-to-child transmission of HIV. In 2010, 48% [44% 54%] of the estimated 1.5 million pregnant women living with HIV in low- and middle-income countries received most effective antiretroviral treatment to reduce the risk of HIV transmission to their infants, and for their own health. (This figure excludes single-dose nevirapine, which is no longer recommended in WHO s guidelines to treat pregnant mothers and prevent HIV infection among children.) Coverage was highest in Europe and Central Asia (79% [65% 94%]), and lowest in the Middle East Number of women receiving antiretroviral treatment to prevent new HIV infections among children, by region, THOUSANDS North Africa and Middle East Caribbean Latin America Europe and Central Asia East, South & South East Asia Sub-Saharan Africa UNAIDS DATA TABLES

10 and North Africa (4% [3% 6%]), East, South and South-East Asia (16% [13% 23%]), and in West and Central Africa (18% [15% 20%]). In East and Southern Africa, the subregion with the largest number of pregnant women living with HIV, antiretroviral coverage reached 64% [57% 71%] in Impressively, five of the 22 priority low- and middle-income countries have reached the 80% target set by the United Nations General Assembly Special Session for antiretroviral coverage for pregnant women living with HIV: Botswana (>95%), Lesotho (89%), Namibia >95%), South Africa (>95%) and Swaziland (>95%). But coverage is still low in several other priority countries, including Angola (20%), Burundi (36%), Chad (7%), Democratic Republic of the Congo (1%), and Nigeria (9%). In low- and middle-income countries overall, 42% [38% 48%] of the estimated 1.5 million infants born to mothers living with HIV received antiretroviral prophylaxis in 2010, compared with 32% [29% 36%] the year before. However, coverage of antiretroviral prophylaxis for infants has stayed lower than for their mothers, which indicates that loss to follow-up of mother-infant pairs remains a significant challenge. Infant antiretroviral prophylaxis coverage rates continue to vary dramatically between regions and subregions. In 2010, it was highest in Europe and Central Asia (75%, [63% 91%]), and lowest in West and Central Africa (14%, [12% 16%]). There were strong gains in East and Southern Africa, where coverage increased from 41% [36% 45%] to 55% [50% 62%] in In Latin America and the Caribbean, and in East, South and South-East Asia, coverage in stayed about the same. Although the most effective strategy for preventing paediatric HIV infections and mortality is the expansion of programmes that prevent mother-to-child transmission, many AIDS-related deaths among HIV-infected children could be avoided through early HIV diagnosis among children and timely provision of effective care and treatment. HIV care and treatment services for HIV-exposed and HIVinfected children are expanding in resource-limited settings, but they remain inadequate. Of the two million [ million] children estimated to be in need of antiretroviral therapy in 2010, only 23% [20% 25%] had access to treatment, compared with 51% of adults [48% 54%]. Again, there is considerable variation across regions. Coverage of paediatric antiretroviral therapy increased substantially only in Europe and Central Asia, from 56% [47% 60%] to 65% [55 71%] in In the same period, coverage in sub-saharan Africa hardly changed, and stood at a low 21% [19% 24%] in Within that region, coverage increased slightly in East and Southern Africa, from 23% [21% 26%] to 26% [23% 29%], and an estimated children where receiving antiretroviral therapy there in But in West and Central Africa, coverage remained a mere 9% [8% 11%], which translated into about children getting antiretroviral therapy in 2010, up from a year earlier. Coverage was unchanged in East, South and South-East Asia at 39% [30% 52%] in 2010, and in North Africa and the Middle East at 5% [3% 7%]) but decreased in Latin America and the Caribbean, from 45% [38% 55%] to 39% [32% 48%], in UNAIDS DATA TABLES 2011

11 Several of the 25 high-burden countries increased coverage of antiretroviral therapy for children between 2009 and 2010, but Botswana and Thailand had the highest levels of coverage of 88% and 69% respectively. Chad (5%) and Sudan (2%) had the lowest levels of coverage among these countries. Estimated number of women living with HIV needing and receiving antiretrovirals to prevent new HIV infections among children, and coverage excluding single-dose nevirapine in low- and middle-income countries, by geographical region, 2010 Number of pregnant women Estimated number of pregnant Estimated coverage, living with HIV receiving any women living with HIV in need of excluding reported antiretrovirals to prevent new antiretrovirals to prevent new HIV single-dose Geographical region HIV infections among children infections among children nevirapine Sub-Saharan Africa East and Southern Africa West and Central Africa Latin America & Caribbean Latin America Caribbean [ ] [ ] [ ] [ ] [ ] [ ] 50% [44% 56%] 64% [57% 71%] 18% [15% 20%] 59% [46% 90%] 64% [47% >95%] 46% [37% 57%] East, South & South East Asia [ ] 16% [13% 23%] Eastern Europe & Central Asia [ ] 79% [65% 94%] North Africa & Middle East [ ] 4% [3% 6%] All low- and middle-income countries [ ] 48% [44% 54%] UNAIDS DATA TABLES

12

13 DATA TABLES 2011

14 Table 1 Number of people receiving antiretroviral treatment Country Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros

15 Number of people receiving antiretroviral treatment Country Congo, Republic of the Costa Rica C te d'ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia The Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland

16 Number of people receiving antiretroviral treatment Country India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao PDR Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia, Federated States of Moldova Monaco Mongolia Montenegro

17 Number of people receiving antiretroviral treatment Country Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent & the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone

18 Number of people receiving antiretroviral treatment Country Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syria Tajikistan Tanzania Thailand The former Yugoslav Republic of Macedonia Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Vanuatu Venezuela Vietnam Yemen Zambia

19 Number of people receiving antiretroviral treatment Country Zimbabwe Footnotes 1 Dec. 2009; Updated 2009 value. See last year's annex ( 2 Dec Dec Dec Sept Dec Sept Oct Updated 2009 value. See last year's annex ( 10 Nov Aug <05' indicates that data exist but no update has been received since December These data should be interpreted cautiously, as they may reflect the situation in early 2004 or even Jan Dec Jun Mar Dec. 2010; As it only reflects 90% of data received from facilities, this number is underreported. 18 Mar Jul Apr Jun Nov Jan Jul Feb. 2010

20 Table 2 Estimated coverage of antiretroviral treatment Country estimate low estimate high estimate estimate low estimate high estimate Afghanistan 1% 0% 3% 3% 1% 6% Algeria 28% 22% 36% 32% 25% 43% Angola 27% 21% 36% 33% 25% 43% Argentina 82% 73% 95% 79% 68% 89% Armenia 23% 14% 53% 30% 14% 49% Azerbaijan 21% 15% 29% 32% 24% 43% Bangladesh 33% 19% 43% 33% 26% 46% Belarus 38% 25% 60% 51% 33% 75% Belize 48% 42% 56% 53% 47% 60% Benin 53% 48% 59% 58% 52% 65% Bhutan 20% 8% 28% 27% 20% 45% Bolivia 17% 9% 30% 20% 10% 37% Botswana 90% 87% >95% 93% 89% >95% Brazil 70% 66% 75% 70% 65% 75% Bulgaria 26% 20% 33% 24% 19% 30% Burkina Faso 44% 40% 49% 49% 44% 55% Burundi 27% 24% 29% 34% 31% 40% Cambodia 86% 62% >95% 92% 68% >95% Cameroon 35% 32% 39% 38% 34% 43% Cape Verde 45% 32% 60% 43% 32% 61% Central African Republic 25% 22% 27% 24% 21% 27% Chad 44% 38% 51% 39% 33% 46% Chile >95% 56% >95% 88% 52% >95% China 23% 18% 30% 32% 26% 37% Colombia 19% 14% 25% 34% 26% 45% Comoros >95% 92% >95% >95% 35% >95% Congo, Republic of the 25% 22% 29% 42% 36% 49% Costa Rica 65% 56% 74% 65% 57% 76% d'ivoire 36% 33% 40% 37% 34% 41% Croatia 83% 66% >95% 89% 70% >95% Cuba >95% 83% >95% 95% 78% >95% Democratic Republic of the Congo... 11% 15%... 13% 16% Djibouti 17% 14% 23% 19% 1% >95% Dominican Republic 62% 54% 71% 72% 62% 82% Ecuador 39% 29% 56% 63% 45% 91% Egypt 7% 3% 18% 10% 4% 21% El Salvador 94% 68% >95% 59% 36% 82%

21 Estimated coverage of antiretroviral treatment Country estimate low estimate high estimate estimate low estimate high estimate Equatorial Guinea 21% 14% 28% 24% 18% 37% Eritrea 41% 25% 77% 42% 23% 68% Ethiopia Fiji 35% 26% 47% 33% 24% 43% Gabon 50% 35% 69% 53% 38% 75% Gambia The 20% 9% 41% 35% 17% 78% Georgia 62% 23% >95% 65% 20% >95% Ghana 28% 25% 32% 35% 31% 40% Guatemala 51% 31% >95% 53% 23% 89% Guinea 47% 40% 56% 57% 47% 67% Guinea-Bissau... 33% 52%... 39% 59% Guyana 66% 47% >95% 84% 59% >95% Haiti 50% 44% 58% 51% 45% 58% Honduras 45% 36% 59% 51% 39% 65% Hungary 34% 27% 43% 38% 30% 48% India % 38% Indonesia 24% 16% 35% 24% 17% 35% Iran 6% 5% 7% 7% 1% 4% Jamaica 53% 43% 66% 57% 46% 69% Kazakhstan 27% 23% 31% 30% 26% 35% Kenya 52% 49% 55% 61% 56% 66% Kyrgyzstan 6% 3% 10% 12% 7% 21% Lao PDR 48% 31% 77% 51% 33% 73% Latvia 17% 14% 22% 18% 14% 23% Lebanon 35% 22% 53% 37% 25% 55% Lesotho 52% 49% 55% 57% 53% 60% Liberia 19% 16% 23% 27% 23% 32% Lithuania 29% 23% 37% 27% 21% 34% Madagascar 1% 1% 1% 1% 1% 2% Malawi... 43% 49%... 49% 57% Malaysia 27% 22% 36% 36% 27% 44% Maldives 22% 19% 27% 14% 11% 17% Mali 43% 37% 50% 46% 39% 56% Mauritania 21% 14% 33% 22% 14% 33% Mauritius 28% 22% 36% 16% 14% 18% Mexico 81% 55% >95% 78% 59% >95% Moldova 25% 21% 30% 25% 21% 30%

22 Estimated coverage of antiretroviral treatment Country estimate low estimate high estimate estimate low estimate high estimate Mongolia 11% 5% 14% 26% 19% 39% Morocco 27% 20% 41% 30% 19% 39% Mozambique 40% 36% 46% 40% 36% 46% Myanmar 17% 15% 19% 24% 21% 27% Namibia 78% 66% 92% 90% 78% >95% Nepal 12% 9% 20% 18% 11% 26% Nicaragua >95% 41% >95% >95% 45% >95% Niger 26% 24% 29% 29% 26% 33% Nigeria 24% 22% 26% 26% 24% 28% Oman 52% 42% 68% 44% 33% 54% Pakistan 8% 5% 17% 9% 4% 13% Panama 32% 22% 52% 36% 22% 54% Papua New Guinea 54% 44% 67% 54% 43% 65% Paraguay 53% 30% 89% 66% 38% >95% Peru 62% 43% 84% 57% 41% 84% Philippines 39% 19% 53% 51% 38% 83% Poland 32% 24% 42% 34% 25% 44% Romania 69% 62% 79% 69% 60% 77% Russian Federation... 22% 32%... 21% 29% Rwanda 81% 75% 93% 88% 76% >95% Sao Tome and Principe 32% 24% 43% 34% 25% 46% Senegal 56% 44% 70% 50% 39% 64% Serbia 33% 24% 42% 34% 26% 45% Sierra Leone 23% 19% 26% 31% 27% 38% Slovakia 75% 58% >95% 81% 63% >95% Somalia 3% 2% 3% 2% 3% 5% South Africa 42% 40% 44% 55% 52% 58% Sri Lanka 23% 17% 30% 25% 19% 34% Sudan 4% 3% 6% 5% 2% 5% Suriname 39% 27% 59% 45% 69% >95% Swaziland 63% 59% 67% 72% 67% 76% Tajikistan 11% 6% 22% 16% 9% 27% Tanzania 33% 31% 36% 42% 39% 46% Thailand 61% 48% 75% 67% 55% 85% Togo 38% 34% 43% 50% 44% 56% Tunisia 11% 5% 33% 10% 3% 24% Turkey 67% 53% 87% 56% 45% 72%

23 Estimated coverage of antiretroviral treatment Country estimate low estimate high estimate estimate low estimate high estimate Uganda 42% 40% 45% 47% 43% 51% Ukraine 9% 8% 12% 13% 11% 16% Uruguay 58% 37% >95% 71% 32% >95% Uzbekistan 22% 12% 40% 28% 16% 47% Venezuela 53% 44% 62% 57% 47% 69% Vietnam 44% 37% 53% 52% 43% 61% Zambia 66% 63% 70% 72% 67% 77% Zimbabwe 41% 39% 44% 59% 54% 62%

24 Table 3 Number of pregnant women living with HIV who received antiretroviral treatment for preventing new HIV infection among children Country Afghanistan Albania Algeria Angola Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo, Republic of the Costa Rica C te d'ivoire Croatia Cuba Democratic People's Republic of Korea Democratic Republic of the Congo Djibouti Dominica Dominican Republic

25 Number of pregnant women living with HIV who received antiretroviral treatment for preventing new HIV infection among children Country Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Gabon Gambia The Georgia Ghana Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao PDR Latvia Lebanon Lesotho Liberia Libya Lithuania Madagascar Malawi

26 Number of pregnant women living with HIV who received antiretroviral treatment for preventing new HIV infection among children Country Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia, Federated States of Moldova Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent & the Grenadines Samoa Sao Tome and Principe Senegal

27 Number of pregnant women living with HIV who received antiretroviral treatment for preventing new HIV infection among children Country Serbia Seychelles Sierra Leone Slovakia Solomon Islands Somalia South Africa Sri Lanka Sudan Suriname Swaziland Syria Tajikistan Tanzania Thailand The former Yugoslav Republic of Macedonia Timor Leste Togo Tonga Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine Uruguay Uzbekistan Vanuatu Venezuela Vietnam Yemen Zambia Zimbabwe

28 Footnotes 1 As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total. Reporting Period: Jan Dec Excluding single-dose nevirapine; Reporting Period: Jan Dec Excluding single-dose nevirapine; The data are underreported, incomplete or are not representative of the population. Reporting Period: Jan Dec Excluding single-dose nevirapine; Reporting Period: Jan Dec As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total; The data are underreported, incomplete or are not representative of the population. Reporting Period: Jan Dec Excluding single-dose nevirapine; Data were collected from CWM Hospital, Lautoka Hospital and Labasa Hospital. Reporting Period: Jan Dec Excluding single-dose nevirapine; Reporting Period: Sep Sep As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total. Reporting Period: Oct Sep As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total. Reporting Period: Jan Dec As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total; Two separate reports were received from Sudan: Southern Sudan reported 559 in 2010; Northern Sudan reported 110 for the reporting period from January to December 2010, giving a total of 669. Adjusted value (see footnote above). Reporting Period: Jan Dec As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total; The data may include double counting; Two separate reports were received from the United Republic of Tanzania: Tanzania Mainland reported to December 2010; Zanzibar reported 310 for the reporting period from January to December 2010, giving a total of Adjusted value (see footnote above). Reporting Period: Jan Dec Excluding single-dose nevirapine; Reporting Period: Oct Sep As only the most effective regimens as recommended by WHO are reported here, the value for single-dose nevirapine value has been excluded from the total. In case the country also reported a number of women receiving an unspecified antiretroviral medicine, this has proportionally increased the value for single-dose nevirapine deducted from the reported total. Reporting Period: Jul Jun. 2010

29 Table 4 Estimated coverage of pregnant women living with HIV who received effective antiretroviral regimens for preventing new HIV infection among children Country 2010 estimate low estimate high estimate Afghanistan % 0% Albania Algeria % 33% Angola 20% 2 15% 28% Argentina... 2 >95% >95% Armenia % >95% Azerbaijan % 46% Bangladesh % 20% Belarus % >95% Belize % 62% Benin 21% 1 18% 26% Bhutan % 42% Bolivia % >95% Bosnia and Herzegovina Botswana >95% 2 >95% >95% Brazil % >95% Bulgaria % 35% Burkina Faso 35% 2 28% 42% Burundi 36% 2 32% 49% Cambodia % 40% Cameroon 53% 1 43% 65% Cape Verde % >95% Central African Republic 24% 2 19% 29% Chad 7% 2 5% 9% Chile % >95% China % 48% Colombia % 80% Comoros % >95% Congo, Republic of the 16% 2 14% 20% Costa Rica % 24% C te d'ivoire 66% 3 54% 79% Croatia % 40% Cuba % >95% Democratic People's Republic of Korea Democratic Republic of the Congo 1% 1 <1% 1% Djibouti 6% 2 4% 9% Dominica

30 Estimated coverage of pregnant women living with HIV who received effective antiretroviral regimens for preventing new HIV infection among children Country 2010 estimate low estimate high estimate Dominican Republic % 91% Ecuador % >95% Egypt % 10% El Salvador % 47% Equatorial Guinea 6% 5 4% 9% Eritrea 3% 1 1% 7% Ethiopia Fiji % >95% Gabon 49% 1 34% 72% Gambia The % 0% Georgia % >95% Ghana 48% 2 40% 57% Grenada Guatemala % 87% Guinea 23% 2 17% 30% Guinea-Bissau 30% 1 25% 38% Guyana % >95% Haiti 40% 1 34% 49% Honduras % >95% Hungary % 33% India Indonesia % 15% Iran % 23% Iraq Jamaica % 88% Jordan Kazakhstan % >95% Kenya 43% 1 37% 49% Kiribati Kyrgyzstan % 36% Lao PDR % 15% Latvia % 92% Lebanon Lesotho 89% 2 77% >95% Liberia 38% 2 29% 53% Libya Lithuania % >95%

31 Estimated coverage of pregnant women living with HIV who received effective antiretroviral regimens for preventing new HIV infection among children Country 2010 estimate low estimate high estimate Madagascar... 2 <1% 1% Malawi % 31% Malaysia % 53% Maldives % 0% Mali % 34% Marshall Islands Mauritania % 13% Mauritius % >95% Mexico % 31% Micronesia, Federated States of Moldova % 87% Mongolia % 17% Montenegro Morocco % 39% Mozambique 52% 1 44% 62% Myanmar % >95% Namibia >95% 1 79% >95% Nauru Nepal % 14% Nicaragua % >95% Niger % 62% Nigeria 9% 1 7% 10% Oman % >95% Pakistan % 2% Palau Panama % 80% Papua New Guinea 16% 2 13% 22% Paraguay % >95% Peru % >95% Philippines % 8% Poland % 48% Romania... 2 >95% >95% Russian Federation % 84% Rwanda 60% 1 50% 75% Saint Kitts and Nevis Saint Lucia Saint Vincent & the Grenadines

32 Estimated coverage of pregnant women living with HIV who received effective antiretroviral regimens for preventing new HIV infection among children Country 2010 estimate low estimate high estimate Samoa Sao Tome and Principe % >95% Senegal % 42% Serbia % 7% Seychelles Sierra Leone 62% 2 51% 77% Slovakia % 0% Solomon Islands Somalia... 1 <1%... South Africa >95% 2 85% >95% Sri Lanka % 6% Sudan 2% 11 1% 4% Suriname % >95% Swaziland >95% 2 88% >95% Syria Tajikistan % 38% Tanzania 59% 12 52% 68% Thailand % >95% The former Yugoslav Republic of Macedonia Timor Leste Togo 51% 2 43% 60% Tonga Tunisia % 11% Turkey % 0% Turkmenistan Tuvalu Uganda 42% 14 36% 51% Ukraine... 1 >95% >95% Uruguay % >95% Uzbekistan % >95% Vanuatu Venezuela % 12% Vietnam % 46% Yemen Zambia 75% 1 67% 85% Zimbabwe 46% 1 40% 52%

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of

More information

מדינת ישראל. Tourist Visa Table

מדינת ישראל. Tourist Visa Table Updated 23/05/2017 מדינת ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Exe = exempted Req = required Press the first

More information

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Updated 25/05/2015 ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. (C) Bearers of official passports requiring tourist

More information

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2011 APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS (SEE TABLE 4.9) Africa The Americas South-East Asia Europe Eastern Mediterranean Western Pacific

More information

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts (charts in colour) (These charts will be updated in 2014) 2 1. Introduction 2. Instructions on how to use

More information

Eligibility List 2018

Eligibility List 2018 The Global Fund s 2017-2022 strategy and allocation-based approach enables strategic investment to accelerate the end of HIV/AIDS, tuberculosis and malaria and build resilient and sustainable systems for

More information

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 Current State of Global HIV Care Continua Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 1) International Association of Providers of AIDS Care

More information

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS More information about out-of-bundle charges for our small business customers calling internationally from the UK using a small business price plan Page

More information

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss Mortality and Burden of Diseases and Prevention of Blindness and Deafness WHO, 2012 In 2012, WHO released

More information

THE CARE WE PROMISE FACTS AND FIGURES 2017

THE CARE WE PROMISE FACTS AND FIGURES 2017 THE CARE WE PROMISE FACTS AND FIGURES 2017 2 SOS CHILDREN S VILLAGES INTERNATIONAL WHERE WE WORK Facts and Figures 2017 205 58 79 families and transit 31 Foster homes 162 8 3 173 214 2 115 159 136 148

More information

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget UNITED NATIONS Distr. GENERAL 13 October 1997 ENGLISH ONLY SUBSIDIARY BODY FOR IMPLEMENTATION Seventh session Bonn, 20-29 October 1997 Item 9 of the provisional agenda ADMINISTRATIVE AND FINANCIAL MATTERS

More information

FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL. Smoke-free. International Status Report

FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL. Smoke-free. International Status Report FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL Smoke-free Environments International Status Report As December, 00 Smoke-free environments are a vital part combating the global tobacco

More information

ANNEX 3: Country progress indicators

ANNEX 3: Country progress indicators : progress indicators 541 : COUNTRY PROGRESS INDICATORS 2006 REPORT ON THE GLOBAL AIDS EPIDEMIC Annex 3 : COUNTRY PROGRESS INDICATORS As of March 2006, 115 countries had reported indicators on progress

More information

Maternal Deaths Disproportionately High in Developing Countries

Maternal Deaths Disproportionately High in Developing Countries EMBARGOED until Monday, 20 October, 6am GMT HQ/2003/24 20 October 2003 CF/DOC/PR/2003-82 Maternal Deaths Disproportionately High in Developing Countries African women are 175 times more likely to die in

More information

WHO report highlights violence against women as a global health problem of epidemic proportions

WHO report highlights violence against women as a global health problem of epidemic proportions News release WHO/16 20 June 2013 EMBARGO: PLEASE DO NOT DISTRIBUTE OR PUBLISH BEFORE THURSDAY 20 JUNE 2013 AT 15H00 GENEVA TIME, 14H00 LONDON TIME, 13H00 GMT, AND 09H00 EST WHO report highlights violence

More information

Annex 2 A. Regional profile: West Africa

Annex 2 A. Regional profile: West Africa Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262

More information

GLOBAL RepORt UNAIDS RepoRt on the global AIDS epidemic

GLOBAL RepORt UNAIDS RepoRt on the global AIDS epidemic GLOBAL Report UNAIDS Report on the global AIDS epidemic 2012 Copyright 2012 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved The designations employed and the presentation of the

More information

TOBACCO USE PREVALENCE APPENDIX II: The following definitions are used in Table 2.1 and Table 2.3:

TOBACCO USE PREVALENCE APPENDIX II: The following definitions are used in Table 2.1 and Table 2.3: APPENDIX II: TOBACCO USE PREVALENCE Tables 2.1 to 2.4 show country-reported data on tobacco use prevalence among adults and youth, as well as countryreported data on smokeless tobacco use prevalence among

More information

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD The year 2008 witnessed sustained progress in expanding access to HIV prevention, treatment and care services in low- and middle-income countries. With

More information

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ ) 1 / 11 Region/Subregion/ Country Africa Eastern Africa Kenya Madagascar Mauritius Uganda United Republic of Tanzania Northern Africa Algeria Egypt Libya Morocco Sudan Southern Africa Botswana Burkina Faso

More information

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations Briefing on Xpert MTB/RIF. Geneva, 21 February, 2011 Fuad Mirzayev TB Laboratory Strengthening and Diagnostics

More information

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF), Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF), 2008-2010 Claudio Politi and Oumar Sagna Department of Immunization Vaccines and Biologicals, World Health

More information

3.5 Consumption Annual Prevalence Opiates

3.5 Consumption Annual Prevalence Opiates 3.5 Consumption 3.5.1 Annual Prevalence 3.5.1.1 Opiates EUROPE Western and Central Europe OPIATES AMERICA Central America Estonia, 2004 1.5 Panama** 0.2 Luxembourg, 2000 0.9 Honduras*, 2005 0.2 Latvia,

More information

Tipping the dependency

Tipping the dependency BREAKING NEWS Meeting the investment challenge Tipping the dependency balance Domestic investments exceed international investments total reaching US$ 8.6 billion. 40 countries fund more than 70% of their

More information

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries Together against Cancer The Advisory Group on Increasing Access to Radiotherapy To address the

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Liyanage T, Ninomiya T, Jha V, et al. Worldwide

More information

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child BCG and your baby Protecting babies against TB Immunisation the safest way to protect your child This leaflet is about the BCG (Bacillus Calmette-Guerin) vaccination that is being offered to protect your

More information

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic. HEALTH & WELLNESS SERVICES INSTRUCTIONS FOR COMPLETING THE REQUIRED MEDICAL FORMS FOR: U.S. CITIZENS 18 YEARS OF AGE OR OLDER AT THE TIME THE FORMS ARE COMPLETED. THIS REQUIREMENT MUST BE COMPLETED WHETHER:

More information

Copyright 2010 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Copyright 2010 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved OVERVIEW: UNAIDS REPORT ON THE GLOBAL AIDS EPIDEMIC 2010 Copyright 2010 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved The designations employed and the presentation of the material

More information

Why Invest in Nutrition?

Why Invest in Nutrition? Why Invest in Nutrition? Meera Shekar Human Development Network World Bank 2006 Three key Issues Why reducing malnutrition is essential to poverty reduction? Is malnutrition a BIG problem? How can we improve

More information

ICM: Trade-offs in the fight against HIV/AIDS

ICM: Trade-offs in the fight against HIV/AIDS ICM: Trade-offs in the fight against HIV/AIDS 1 As the HIV/AIDS pandemic enters its 25 th year, both the number of infections and number of deaths due to the disease continue to rise. Despite an enormous

More information

This portion to be completed by the student Return by July 1 Please use ballpoint pen

This portion to be completed by the student Return by July 1 Please use ballpoint pen This portion to be completed by the student Return by July 1 Please use ballpoint pen Start term: Fall Exploration Spring Summer Year: Class year: Freshman Sophomore Junior Senior Transfer Full name: Preferred:

More information

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided Student Information: Date of Birth: There are two ways to provide us with your immunization information. 1) Students can have their healthcare provider fill out and sign the form below. A healthcare provider

More information

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017 UNAIDS 2017 REFERENCE UNAIDS DATA 2017 Copyright: 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material in this publication

More information

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017 UNAIDS 2017 REFERENCE UNAIDS DATA 2017 Copyright: 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material in this publication

More information

Articles. Funding Bill & Melinda Gates Foundation.

Articles. Funding Bill & Melinda Gates Foundation. Global, regional, and national burden of traumatic brain injury and spinal cord injury, : a systematic analysis for the Global Burden of Disease Study 2016 GBD 2016 Traumatic Brain Injury and Spinal Cord

More information

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017 UNAIDS 2017 REFERENCE UNAIDS DATA 2017 Copyright: 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material in this publication

More information

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030? Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030? Reuben Granich, MD, MPH Strategic and Scientific Advisor International

More information

World Health Organization Department of Communicable Disease Surveillance and Response

World Health Organization Department of Communicable Disease Surveillance and Response WHO/CDS/CSR/ISR/2000.1 WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases World Health Organization Department of Communicable Disease Surveillance and Response This document has been

More information

Certificate of Immunization

Certificate of Immunization Certificate of Immunization Required of all students (Page 1 of 5) QUESTIONS? 440-775-8180 or student.health@oberlin.edu (e-mail preferred) RETURN TO: Oberlin College Student Health Services 247 W. Lorain

More information

Global Fund Results Fact Sheet Mid-2011

Global Fund Results Fact Sheet Mid-2011 Global Fund Results Fact Sheet Mid-2011 This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach

More information

STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE

STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE UC Hastings Student Health Services (SHS) is committed to providing you the best possible medical care, so we need to know about your medical history and

More information

Stakeholders consultation on strengthened cooperation against vaccine preventable diseases

Stakeholders consultation on strengthened cooperation against vaccine preventable diseases Stakeholders consultation on strengthened cooperation against vaccine preventable diseases Fields marked with * are mandatory. General Context This questionnaire is a working document prepared by the European

More information

Tracking progress in achieving the global nutrition targets May 2014

Tracking progress in achieving the global nutrition targets May 2014 Tracking progress in achieving the global nutrition targets May 2014 Setting targets is a way to galvanize attention and mobilize financial resources around priorities in maternal and child nutrition.

More information

Calls from home residential tariffs

Calls from home residential tariffs These price lists include call charges at the old VAT rate of 17.5%. From 1st December, all of your calls will be billed at the lower VAT rate of 15%, and we ll update these lists to the new rates as soon

More information

Global Fund ARV Fact Sheet 1 st June, 2009

Global Fund ARV Fact Sheet 1 st June, 2009 Global Fund ARV Fact Sheet 1 st June, 2009 This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown

More information

Main developments in past 24 hours

Main developments in past 24 hours ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance

More information

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT THE GLOBAL NET WORK OF CREDIT UNIONS AND FINANCIAL COOPERATIVES MEMBERSHIP AT A GLANCE World Council builds, champions, defends and grows a global

More information

Global and regional burden of first-ever ischaemic and haemorrhagic stroke during : findings from the Global Burden of Disease Study 2010

Global and regional burden of first-ever ischaemic and haemorrhagic stroke during : findings from the Global Burden of Disease Study 2010 Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990 2010: findings from the Global Burden of Disease Study 2010 Rita V Krishnamurthi, Valery L Feigin, Mohammad H Forouzanfar,

More information

Global Fund Mid-2013 Results

Global Fund Mid-2013 Results Global Fund Mid-2013 Results This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach in determining

More information

FORMS MUST BE COMPLETED PRIOR TO THE START OF YOUR FIRST SEMESTER

FORMS MUST BE COMPLETED PRIOR TO THE START OF YOUR FIRST SEMESTER HEALTH & WELLNESS SERVICES INSTRUCTIONS FOR COMPLETING THE REQUIRED MEDICAL FORMS FOR: U.S. CITIZENS WHO ARE NOT 18 YEARS OF AGE AT THE TIME THE FORMS ARE COMPLETED. THIS REQUIREMENT MUST BE COMPLETED

More information

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic levels, as understaffing is a chronic issue in all the countries that are scaling up male circumcision. Current achievements notwithstanding, it is necessary to reinforce and strengthen national political

More information

Global Measles and Rubella Update. April 2018

Global Measles and Rubella Update. April 2018 Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct

More information

Update: Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB

Update: Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB Update: Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB DOTS Expansion Working Group Meeting Lille, France 25 th October 2011 Christopher Gilpin PhD MPH TB Diagnostics and Laboratory Strengthening

More information

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Donor Support for Contraceptives and Condoms for STI/HIV Prevention Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2001 Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2001 Table of Contents List of Abbreviations and Acronyms List

More information

STAT/SOC/CSSS 221 Statistical Concepts and Methods for the Social Sciences. Introduction to Mulitple Regression

STAT/SOC/CSSS 221 Statistical Concepts and Methods for the Social Sciences. Introduction to Mulitple Regression STAT/SOC/CSSS 1 Statistical Concepts and Methods for the Social Sciences Introduction to Mulitple Regression Christopher Adolph Department of Political Science and Center for Statistics and the Social

More information

REQUIRED COLLEGIATE START. (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION

REQUIRED COLLEGIATE START. (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION REQUIRED COLLEGIATE START (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION Complete this form and return by July 1 st to: STUDENT HEALTH SERVICES

More information

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000) Recent trends in malnutrition in developing regions 109 Annex 1 Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, ) The tables in this Annex

More information

Global Measles and Rubella Update November 2018

Global Measles and Rubella Update November 2018 Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep

More information

UNDERGRADUATE STUDENT HEALTH PACKET

UNDERGRADUATE STUDENT HEALTH PACKET UNDERGRADUATE STUDENT HEALTH PACKET Deadlines: Fall: July 15 th Spring: December 1st Enclosed Forms/Documents: Type of Students Required For: Comments: Undergraduate Vaccine Form Physical Examination Form

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Troeger C, Khalil IA, Rao PC, et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. JAMA Pediatr. Published online August

More information

Implementation of the International Health Regulations (2005)

Implementation of the International Health Regulations (2005) SIXTY-EIGHTH WORLD HEALTH ASSEMBLY A68/22 Provisional agenda item 15.3 15 May 2015 Implementation of the International Health Regulations (2005) Responding to public health emergencies Report by the Director-General

More information

The worldwide societal costs of dementia: Estimates for 2009

The worldwide societal costs of dementia: Estimates for 2009 Alzheimer s & Dementia 6 (2010) 98 103 The worldwide societal costs of dementia: Estimates for 2009 Anders Wimo a, *, Bengt Winblad a, Linus Jönsson b a KI-Alzheimer s Disease Research Center, Department

More information

Country Profiles for Population and Reproductive Health: Policy Developments and Indicators 2003

Country Profiles for Population and Reproductive Health: Policy Developments and Indicators 2003 Country Profiles for Population and Reproductive Health: Policy Developments and Indicators 2003 Copyright United Nations Population Fund and Population Reference Bureau, 2003. Acknowledgements This publication

More information

Annual prevalence estimates of cannabis use in the late 1990s

Annual prevalence estimates of cannabis use in the late 1990s Cocaine abuse in most east European countries, by contrast, is still far less widespread and less of a problem. A majority of countries in eastern Europe either did not report on cocaine at all, or they

More information

DEMOGRAPHIC CHANGES IN DEVELOPED AND DEVELOPING COUNTRIES

DEMOGRAPHIC CHANGES IN DEVELOPED AND DEVELOPING COUNTRIES Clemson University TigerPrints All Theses Theses 8-2013 DEMOGRAPHIC CHANGES IN DEVELOPED AND DEVELOPING COUNTRIES Sarah Sax Clemson University, sarahsax9@gmail.com Follow this and additional works at:

More information

Reproductive Health Policies 2017

Reproductive Health Policies 2017 E c o n o m i c & S o c i a l A f f a i r s Reproductive Health Policies 2017 United Nations Data Booklet Reproductive Health Policies 2017 Reproductive health is critical to achieving the Goals of the

More information

World Pre-trial / Remand Imprisonment List

World Pre-trial / Remand Imprisonment List Inter Centre for Prison Studies World Pre-trial / Remand Imprisonment List (Pre-trial detainees and other prisoners in all five continents) Roy Walmsley Introduction The World Remand Imprisonment List

More information

Health Services Immunization and Health Information

Health Services Immunization and Health Information Your complete record for required vaccines (Part II) must be on file in our Health Center before the start of classes or you will be MEDICALLY WITHDRAWN FROM CLASSES per NYS Public Health Laws 2165 and

More information

The Single Convention on Narcotic Drugs- Implementation in Six Countries: Albania, Bangladesh, India, Kyrgyzstan, Sri Lanka, Ukraine

The Single Convention on Narcotic Drugs- Implementation in Six Countries: Albania, Bangladesh, India, Kyrgyzstan, Sri Lanka, Ukraine The Single Convention on Narcotic Drugs- Implementation in Six Countries: Albania, Bangladesh, India, Kyrgyzstan, Sri Lanka, Ukraine A MONOGRAPH PREPARED FOR: International Pain Policy Fellowship Training

More information

STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a and Fairfield

STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a and Fairfield STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a - 155 and Fairfield University require each full-time or matriculating student

More information

Dear New Student and Family,

Dear New Student and Family, Dear New Student and Family, Enclosed is information regarding the health documents that students must (1) take to their health care provider and (2) upload prior to arriving at Moravian College. Everything

More information

The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms.

The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms. IMMUNIZATIONS The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms. To ensure the safety of all students, Drexel requires all full-time

More information

NON-STANDARD PRICE GUIDE FOR EE SMALL BUSINESS More information about out-of-bundle charges for our small business customers

NON-STANDARD PRICE GUIDE FOR EE SMALL BUSINESS More information about out-of-bundle charges for our small business customers NON-STANDARD PRICE GUIDE FOR EE SMALL BUSINESS More information about out-of-bundle charges for our small business customers B2BLegal1204 Non-Standard Price Guide for EE Small Business EXT Document v2.8

More information

STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring semester)

STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring semester) Castleton University Wellness Center counseling, nursing, wellness education STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring

More information

Epidemiological Estimates for Haemoglobin Disorders: WHO South East Asian Region by Country

Epidemiological Estimates for Haemoglobin Disorders: WHO South East Asian Region by Country Epidemiological Estimates for Haemoglobin Disorders: WHO South East Asian Region by Comprising the following charts and tables: Chart 1: Population Chart 2: Annual births Chart 3: Crude birth rate and

More information

Student Health Center Mandatory Immunization Information

Student Health Center Mandatory Immunization Information 2009-2010 Mandatory Immunization Information The District of Columbia Immunization Law requires that all students, under age 26 (except for students who meet statutory requirements for exemption based

More information

Welcomes New Students

Welcomes New Students Health Report Student Name: Banner # Date of Birth: Student Health Service Welcomes New Students Student s Health Information Completed form should be mailed, faxed or emailed to Student Health Service.

More information

Global, regional, and national burden of Parkinson s disease, : a systematic analysis for the Global Burden of Disease Study 2016

Global, regional, and national burden of Parkinson s disease, : a systematic analysis for the Global Burden of Disease Study 2016 Global, regional, and national burden of Parkinson s disease, 1990 2016: a systematic analysis for the Global Burden of Disease Study 2016 GBD 2016 Parkinson s Disease Collaborators* Summary Background

More information

Name DOB / / LAST FIRST MI Home Address: Street City: State: Zip: Name of Parent/Guardian(Emergency Contact) Relationship Contact Phone Number

Name DOB / / LAST FIRST MI Home Address: Street City: State: Zip: Name of Parent/Guardian(Emergency Contact) Relationship Contact Phone Number Page 1 of 6 OFFICE OF HEALTH SERVICES York College of PA York PA 17403-3651 (717) 849-1615 Fax: (717) 849-1601 email: healthcenter@ycp.edu DEADLINES: Fall: August 1; Spring: January 1 Name DOB / / LAST

More information

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates

More information

Global, regional, and national burden of Alzheimer's disease and other dementias,

Global, regional, and national burden of Alzheimer's disease and other dementias, https://helda.helsinki.fi Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016 Nichols, Emma 2019-01 GBD 2016 Dementia Collaborators 2019, ' Global, regional, and

More information

Global Measles and Rubella Update October 2018

Global Measles and Rubella Update October 2018 Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug

More information

FACTS AND FIGURES 2015 OUR VILLAGE

FACTS AND FIGURES 2015 OUR VILLAGE FACTS AND FIGURES 2015 OUR VILLAGE FOREWORD WHAT WE DO OUR WORK IN 2015 SOS Children s Villages communities provide a range of services in care, education, health and emergency response, depending on local

More information

Think piece: Why is 2018 a strategically important year for NCDs?

Think piece: Why is 2018 a strategically important year for NCDs? WHO Independent High-level Commission on NCDs Think piece: Why is 2018 a strategically important year for NCDs? The NCD crisis: Priorities for 2018 This year may be remembered as a watershed in the global

More information

The IB Diploma Programme Statistical Bulletin. November 2015 Examination Session. Education for a better world

The IB Diploma Programme Statistical Bulletin. November 2015 Examination Session. Education for a better world The IB Diploma Programme Statistical Bulletin November 2015 Examination Session Education for a better world TheIBDiplomaProgrammeStatisticalBuletin,November2015ExaminationSession. InternationalBaccalaureate

More information

we are daisy Daisy Conferencing Max Bridge charges* International charges* International toll-free access levy

we are daisy Daisy Conferencing Max   Bridge charges* International charges* International toll-free access levy Daisy Conferencing Max Daisy Conferencing offers three tailored solutions to meet your business requirements. Create simple audio calls on demand with Reservationless Conferencing, audio-visual web conferences

More information

The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny College. Please PRINT legibly.

The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny College. Please PRINT legibly. ALLEGHENY COLLEGE PREMATRICULATION HEALTH STATUS REPORT DEADLINE WINSLOW HEALTH CENTER JULY 1, 2016 The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny

More information

all incoming UWL students MUST submit an up-to-date immunization history, including vaccination dates.

all incoming UWL students MUST submit an up-to-date immunization history, including vaccination dates. Dear Students and Parents, On behalf of the UW La Crosse Student Health Center staff, I would like to welcome you to the University and wish you a productive and healthy college career. We are looking

More information

i-roamfree packs (Revised effective 31 st May 2018) day days days days days days days

i-roamfree packs (Revised effective 31 st May 2018) day days days days days days days TERMS AND CONDITIONS Prepaid International Roaming Packs The Vodafone International roaming packs are provided to Vodafone customers travelling to select locations. i-roamfree packs (Revised effective

More information

Global malaria mortality between 1980 and 2010: a systematic analysis

Global malaria mortality between 1980 and 2010: a systematic analysis Global malaria mortality between 1980 and 2010: a systematic analysis Christopher J L Murray, Lisa C Rosenfeld, Stephen S Lim, Kathryn G Andrews, Kyle J Foreman, Diana Haring, Nancy Fullman, Mohsen Naghavi,

More information

SUBMITTING THE MANDATORY IMMUNIZATION FORM

SUBMITTING THE MANDATORY IMMUNIZATION FORM 2018-2019 Mandatory Immunization Information Please read these instructions carefully. District of Columbia immunization requirements differ from other states and countries. Even though you may have met

More information

Health Status Report

Health Status Report Health Status Report Deadline: June 30 The Health Status Report must be completed in its entirety prior to arriving at Allegheny College. Last Name First Name Middle Initial Gender Home Address (Number

More information

Depression and Other Common Mental Disorders

Depression and Other Common Mental Disorders Depression and Other Common Mental Disorders Global Health Estimates DEPRESSION AND OTHER COMMON MENTAL DISORDERS: GLOBAL HEALTH ESTIMATES 3 Depression and Other Common Mental Disorders Global Health

More information

UNAIDS 2013 AIDS by the numbers

UNAIDS 2013 AIDS by the numbers UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since

More information

Epidemiological Estimates for Haemoglobin Disorders: The World by WHO Region

Epidemiological Estimates for Haemoglobin Disorders: The World by WHO Region Epidemiological Estimates for Haemoglobin Disorders: The World by WHO Comprising the following charts and tables: Chart 1: Population Chart 2: Annual births Chart 3: Crude birth rate and infant mortality

More information

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report October 2013 I N F O R M A T I O N S O U R C E S U S E D: Databases: OIE WAHID World Animal Health

More information